Law Daily Report

'Groundbreaking' Lung Cancer Trial Shows Survival Benefits

  • 📰 Medscape
  • ⏱ Reading Time:
  • 41 sec. here
  • 29 min. at publisher
  • 📊 Quality Score:
  • News: 114%
  • Publisher: 55%

Small Cell Lung Cancer News

Small-Cell Lung Cancer,Oat Cell Lung Cancer,SCLC

The ADRIATIC trial found that adding durvalumab to consolidation treatment increased progression-free survival and added 2 years of life in patients with limited stage small cell lung cancer.

Adding durvalumab as consolidation treatment following concurrent chemoradiation adds 2 years of life and increases progression-free survival by 24% compared with placebo, in patients with limited stage small cell lung cancer .

"ADRIATIC is the first positive, global phase 3 trial of immunotherapy in limited stage SCLC," said Lauren Byers, MD, the discussant in the session. After a median follow-up of 3 years, there was a median OS of 55.9 months in the durvalumab-treated patients compared with 33.4 months in the placebo arm , and, at a median follow-up of 2 years, there was median PFS of 16.6 months vs 9.2 months respectively ."This study had a very good safety profile," said Dr Spigel, who is also a medical oncologist and the chief scientific officer at Sarah Cannon Research Institute in Nashville, Tennessee, during his presentation.

Toby Campbell, MD, a thoracic oncologist, who is professor and chief of Palliative Care at the University of Wisconsin, in Madison, Wisconsin, agrees.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer's drug for advanced lung cancer shows promising long-term trial resultsThe company's medicine helped patients live longer without seeing their cancer progress, as most of them experienced that benefit for over five years.
Source: CNBC - 🏆 12. / 72 Read more »

Groundbreaking human trial for tooth regeneration drug set to beginThe world's first clinical trial of a drug designed to regenerate human teeth is slated to start in a few months, following promising results from animal studies. If successful, the revolutionary treatment could be available commercially by 2030.
Source: WashTimes - 🏆 235. / 63 Read more »

Trump trial live updates: Former president found guilty on all counts in hush money trialAs the first former president charged with a criminal offense, Trump also now becomes the first former president to be convicted of a crime.
Source: ABC7NY - 🏆 592. / 51 Read more »